Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this trial is to assess the safety and acceptability of Tenofovir (TFV) 1% gel in adolescent females over 12 weeks of a minimum of twice weekly dosing following the BAT24 regimen.
Epistemonikos ID: 8bd4b2d70111cfe93fc66360e513cef308f50725
First added on: May 12, 2024